Safety and immunogenicity of a 25-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive healthy adults: Results from 2 randomised, controlled clinical trials.

Saved in:
Bibliographic Details
Title: Safety and immunogenicity of a 25-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive healthy adults: Results from 2 randomised, controlled clinical trials.
Authors: Langley, Joanne M.1 (AUTHOR), Sadarangani, Manish2,3 (AUTHOR), Ockenhouse, Christian4 (AUTHOR), Barreto, Luis5 (AUTHOR), Ye, Lingyun6 (AUTHOR), Tang, Yuxiao4 (AUTHOR), Breeze, Janis L.6 (AUTHOR), Feser, Jodi4 (AUTHOR), Hosken, Nancy A.4 (AUTHOR), Andi-Lolo, Indah1,7 (AUTHOR), Tasker, Sybil A.7 (AUTHOR) stasker@inventprise.com, Halperin, Scott A.6 (AUTHOR)
Source: Vaccine. Mar2026, Vol. 75, pN.PAG-N.PAG. 1p.
Database: Environment Complete
Description
ISSN:0264410X
DOI:10.1016/j.vaccine.2026.128236